Company Founded by Engineering Alumni Advances 1-hour COVID Test
Medical diagnostic company Fluxergy, founded by UC San Diego engineering alumni, submitted an Emergency Use Authorization to the FDA for their quick, point-of-care COVID-19 test.
Medical diagnostic company Fluxergy, founded by UC San Diego engineering alumni, submitted an Emergency Use Authorization to the FDA for their quick, point-of-care COVID-19 test.
UC San Diego Health makes measurable progress addressing COVID-19 testing shortage through multiple partnerships and rapidly growing in-house testing. Success has meant more testing for more patients, first responders and other health systems.
UC San Diego’s Qualcomm Institute is drawing on its unique range of expertise and technology to help in the rapid prototyping and development of medical supplies desperately needed in the fight against COVID-19.
A new study by SDSC researchers describes the use of artificial intelligence machine learning tools to demonstrate a potential RAGE inhibitor that has better efficacy and fewer side effects.
UC San Diego researchers discovered that high blood levels of RNA produced by the PHGDH gene could serve as a biomarker for early detection of Alzheimer’s. The work could lead to the development of a blood test to identify individuals who will develop the disease years before they show symptoms.
Researchers at University of California San Diego School of Medicine are launching a pair of studies to answer critical questions regarding the roles COVID-19 may play in breast milk and pregnancy.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
You have been successfully subscribed to the UC San Diego Today Newsletter.